Verona Pharma plc buy Wells Fargo & Company
Start price
08.01.25
/
50%
€0.51
Target price
08.01.26
€71.72
Performance (%)
-
End price
09.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | 0.444% | 3.030% | 12.677% |
| iShares Nasdaq 100 | 3.819% | 4.073% | 33.152% |
| iShares Nikkei 225® | 1.148% | 6.904% | 45.488% |
| iShares S&P 500 | 2.371% | 2.677% | 25.689% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at Wells Fargo & Company from $64.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten